Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Profit After Tax: 2016-2024

Historic Profit After Tax for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to -$124.7 million.

  • Solid Biosciences' Profit After Tax fell 109.48% to -$42.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$124.7 million, marking a year-over-year decrease of 29.88%. This contributed to the annual value of -$124.7 million for FY2024, which is 29.88% down from last year.
  • Latest data reveals that Solid Biosciences reported Profit After Tax of -$124.7 million as of FY2024, which was down 29.88% from -$96.0 million recorded in FY2023.
  • Over the past 5 years, Solid Biosciences' Profit After Tax peaked at -$72.2 million during FY2021, and registered a low of -$124.7 million during FY2024.
  • Its 3-year average for Profit After Tax is -$102.2 million, with a median of -$96.0 million in 2023.
  • As far as peak fluctuations go, Solid Biosciences' Profit After Tax climbed by 24.68% in 2020, and later dropped by 29.88% in 2024.
  • Over the past 5 years, Solid Biosciences' Profit After Tax (Yearly) stood at -$88.3 million in 2020, then grew by 18.24% to -$72.2 million in 2021, then fell by 19.11% to -$86.0 million in 2022, then dropped by 11.67% to -$96.0 million in 2023, then dropped by 29.88% to -$124.7 million in 2024.